| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Infinity Pharmaceuticals Inc (NASDAQ: INFI)
INFI Technical Analysis
5
| As on 9th Jun 2023 INFI STOCK Price closed @ 0.18 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.08 & Strong Sell for SHORT-TERM with Stoploss of 1.46 we also expect STOCK to react on Following IMPORTANT LEVELS. |
INFISTOCK Price
| Open | 0.18 | Change | Price | % |
| High | 0.19 | 1 Day | -0.01 | -5.26 |
| Low | 0.16 | 1 Week | 0.01 | 5.88 |
| Close | 0.18 | 1 Month | 0.03 | 20.00 |
| Volume | 404500 | 1 Year | -2.50 | -93.28 |
| 52 Week High 2.68 | 52 Week Low 0.14 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| INFI Daily Charts |
INFI Intraday Charts |
Whats New @ Bazaartrend |
INFI Free Analysis |
|
|
INFI Important Levels Intraday
| RESISTANCE | 0.24 |
| RESISTANCE | 0.22 |
| RESISTANCE | 0.21 |
| RESISTANCE | 0.20 |
| SUPPORT | 0.16 |
| SUPPORT | 0.15 |
| SUPPORT | 0.14 |
| SUPPORT | 0.12 |
INFI Forecast May 2024
| 4th UP Forecast | 1.43 |
| 3rd UP Forecast | 1.03 |
| 2nd UP Forecast | 0.78 |
| 1st UP Forecast | 0.53 |
| 1st DOWN Forecast | -0.17 |
| 2nd DOWN Forecast | -0.42 |
| 3rd DOWN Forecast | -0.67 |
| 4th DOWN Forecast | -1.07 |
INFI Weekly Forecast
| 4th UP Forecast | 1.12 |
| 3rd UP Forecast | 0.82 |
| 2nd UP Forecast | 0.63 |
| 1st UP Forecast | 0.45 |
| 1st DOWN Forecast | -0.09 |
| 2nd DOWN Forecast | -0.27 |
| 3rd DOWN Forecast | -0.46 |
| 4th DOWN Forecast | -0.76 |
INFI Forecast2024
| 4th UP Forecast | 5.19 |
| 3rd UP Forecast | 3.58 |
| 2nd UP Forecast | 2.59 |
| 1st UP Forecast | 1.6 |
| 1st DOWN Forecast | -1.24 |
| 2nd DOWN Forecast | -2.23 |
| 3rd DOWN Forecast | -3.22 |
| 4th DOWN Forecast | -4.83 |
Infinity Pharmaceuticals Inc ( NASDAQ USA Symbol : INFI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
INFI Business Profile
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 1/1b clinical trials for the treatment of triple negative breast cancer, solid tumors, and ovarian cancer. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Cambridge, Massachusetts. Address: 1100 Massachusetts Avenue, Cambridge, MA, United States, 02138
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service